These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 25182356

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review.
    Erekosima N, Suarez-Cuervo C, Ramanathan M, Kim JM, Chelladurai Y, Segal JB, Lin SY.
    Laryngoscope; 2014 Mar; 124(3):616-27. PubMed ID: 23832632
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
    Chelladurai Y, Suarez-Cuervo C, Erekosima N, Kim JM, Ramanathan M, Segal JB, Lin SY.
    J Allergy Clin Immunol Pract; 2013 Mar; 1(4):361-9. PubMed ID: 24565541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. One century of allergen-specific immunotherapy for respiratory allergy.
    Incorvaia C, Frati F.
    Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
    [Abstract] [Full Text] [Related]

  • 7. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?
    Nelson HS.
    J Allergy Clin Immunol Pract; 2014 May; 2(2):144-9; quiz 150-1. PubMed ID: 24607040
    [Abstract] [Full Text] [Related]

  • 8. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review.
    Kim JM, Lin SY, Suarez-Cuervo C, Chelladurai Y, Ramanathan M, Segal JB, Erekosima N.
    Pediatrics; 2013 Jun; 131(6):1155-67. PubMed ID: 23650298
    [Abstract] [Full Text] [Related]

  • 9. [Respiratory allergies].
    Chiriac AM, Demoly P.
    Presse Med; 2013 Apr; 42(4 Pt 1):395-404. PubMed ID: 22884514
    [Abstract] [Full Text] [Related]

  • 10. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
    Li MR, Wang XN, Jiang HD, Wang QY, Li YC, Lin J, Jin K, Zhang HL, Li CC.
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):726-31. PubMed ID: 23302557
    [Abstract] [Full Text] [Related]

  • 11. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O, Hörmann K, Klimek L.
    MMW Fortschr Med; 2006 Feb 02; 148(5):28-32. PubMed ID: 16518935
    [Abstract] [Full Text] [Related]

  • 12. [Subcutaneous allergen-specific immunotherapy in patients with asthma and allergic rhinitis. 21st century].
    Martín JP.
    Rev Alerg Mex; 2009 Feb 02; 56(2):27-9. PubMed ID: 19526950
    [No Abstract] [Full Text] [Related]

  • 13. [Preventive immunotherapy].
    Boquete M, Carballada F, Expósito F, González A.
    Allergol Immunopathol (Madr); 2000 Feb 02; 28(3):89-93. PubMed ID: 10867376
    [Abstract] [Full Text] [Related]

  • 14. Changing the route of immunotherapy administration: an 18-year survey in pediatric patients with allergic rhinitis and asthma.
    Pajno GB, Caminiti L, Passalacqua G.
    Allergy Asthma Proc; 2013 Feb 02; 34(6):523-6. PubMed ID: 24169060
    [Abstract] [Full Text] [Related]

  • 15. Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations.
    Cox L.
    Curr Allergy Asthma Rep; 2007 Nov 02; 7(6):410-20. PubMed ID: 17986370
    [Abstract] [Full Text] [Related]

  • 16. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
    Scheinmann P, Pham Thi N, Karila C, de Blic J.
    Arch Pediatr; 2012 Mar 02; 19(3):330-4. PubMed ID: 22306361
    [Abstract] [Full Text] [Related]

  • 17. [Safety of immunotherapy and skin tests with allergens in children younger than five years].
    Rodríguez Pérez N, Ambriz Moreno Mde J.
    Rev Alerg Mex; 2006 Mar 02; 53(2):47-51. PubMed ID: 16884027
    [Abstract] [Full Text] [Related]

  • 18. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O, Wolf H, Klimek L, Schnitker J, Wüstenberg E.
    Clin Ther; 2012 Oct 02; 34(10):2072-81. PubMed ID: 23063373
    [Abstract] [Full Text] [Related]

  • 19. Allergen immunotherapy for allergic rhinitis.
    Okubo K, Gotoh M.
    J Nippon Med Sch; 2010 Dec 02; 77(6):285-9. PubMed ID: 21206140
    [Abstract] [Full Text] [Related]

  • 20. New visions in specific immunotherapy in children: an iPAC summary and future trends.
    Halken S, Lau S, Valovirta E.
    Pediatr Allergy Immunol; 2008 Aug 02; 19 Suppl 19():60-70. PubMed ID: 18665964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.